Drug profile · INN
cysteamine hydrochloride
CYSTADROPS
cysteamine hydrochloride (CYSTADROPS) is a cystine reducing agent. Route of administration: ophthalmic. Current US regulatory status: approved.
Drug details — cysteamine hydrochloride
- US status
- approved
- Class
- —
- Route
- OPHTHALMIC
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
cysteamine hydrochloride (CYSTADROPS) is a cystine reducing agent. Route of administration: ophthalmic. Current US regulatory status: approved.
Key facts
Mechanism of action
Cystine reducing agent
Primary target: Cystine
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is cysteamine hydrochloride?
cysteamine hydrochloride (CYSTADROPS) is a cystine reducing agent. Route of administration: ophthalmic. Current US regulatory status: approved.
What is the brand name for cysteamine hydrochloride?
CYSTADROPS is a marketed brand name for cysteamine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cysteamine hydrochloride?
cysteamine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.